ELANElanco Animal Health Incorporated
$22.92+19% 1Y
$22.92
$18.5452 weeks$26.84
ELAN in its own filings
Nothing in ELAN's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
181
Events found in the filings · across 1,020 filings · the record starts in 2018
- Hard flags
- none
Hard flags
- Most recent filing
- Aug 5, 2026
Most recent filing · Form 10-Q
- Record starts
- Jun 25, 2018
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 4, 2026
- Security removed from listing or deregisteredhistorical · usually a matured note or preferred class, not the common shares
- 2023-02-01
- Material impairmenthistorical
- 2021-06-09
- SEC comment-letter activity15 occurrences
- 2024-03-12
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 5, 2026Elanco Animal Health Reports Second Quarter 2026 Results.Earnings release · press release
- May 6, 2026Elanco Animal Health Reports First Quarter 2026 Results.Earnings release · press release
- Feb 24, 2026Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results.Earnings release · press release
- Dec 9, 2025On December 5, 2025, the Board of Directors of Elanco Animal Health Incorporated (the “Company”) authorized a restructuring plan with respect to its workforce (the “Restructuring Plan”) to support margin expansion, optimize the Company’s footprint, and further invest in innovation.Exit or disposal costs (restructuring) · Form 8-K
- Nov 5, 2025Elanco Animal Health Reports Third Quarter 2025 Results.Earnings release · press release
- Nov 3, 2025On October 31, 2025, Elanco Animal Health Incorporated (the “Company”) entered into Amendment No. 3 to Credit Agreement (“Amendment No. 3”), by and among the Company, as borrower, Elanco US Inc., as co-borrower, Elanco Financing (Netherlands) B.V., as Dutch borrower, the subsidiary loan parties party thereto, the …Material agreement entered · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Drug Manufacturers, Specialty & Generic
Ranks #20 of 41 by RyuScore